Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Strome

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Laryngoscope|May 19, 2001
Epstein-Barr virus DNA is not increased in tonsillar carcinomaN Khabie, A Savva, J L Kasperbauer, et al.
Ear, Nose, & Throat Journal|September 15, 1999
Subglottic carcinoma: review of a series and characterization of its patterns of spreadS E Strome, T C Robey, K O Devaney, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genesM J Arca, J C Krauss, S E Strome, et al.
Ear, Nose, & Throat Journal|January 5, 2002
Sphenoid sinus mucocele: a rare complication of transsphenoidal hypophysectomyF J Buchinsky, T A Gennarelli, S E Strome, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1993
Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanomaS E Strome, J C Krauss, M J Cameron, et al.
Head & Neck|March 1, 1997
Anterior ischemic optic neuropathy following neck dissectionS E Strome, J S Hill, M A Burnstine, et al.
American Journal of Rhinology|September 14, 2001
Endoscopic transnasal pituitary surgery: report on 180 casesS S Nasseri, J L Kasperbauer, S E Strome, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 4, 1999
Squamous cell carcinoma of the buccal mucosaS E Strome, W To, M Strawderman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanomaS E Strome, B Martin, D Flies, et al.
Head & Neck|October 10, 2001
Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapyD Khurana, E A Martin, J L Kasperbauer, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Laryngoscope|May 19, 2001
Epstein-Barr virus DNA is not increased in tonsillar carcinomaN Khabie, A Savva, J L Kasperbauer, et al.
Ear, Nose, & Throat Journal|September 15, 1999
Subglottic carcinoma: review of a series and characterization of its patterns of spreadS E Strome, T C Robey, K O Devaney, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genesM J Arca, J C Krauss, S E Strome, et al.
Ear, Nose, & Throat Journal|January 5, 2002
Sphenoid sinus mucocele: a rare complication of transsphenoidal hypophysectomyF J Buchinsky, T A Gennarelli, S E Strome, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1993
Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanomaS E Strome, J C Krauss, M J Cameron, et al.
Head & Neck|March 1, 1997
Anterior ischemic optic neuropathy following neck dissectionS E Strome, J S Hill, M A Burnstine, et al.
American Journal of Rhinology|September 14, 2001
Endoscopic transnasal pituitary surgery: report on 180 casesS S Nasseri, J L Kasperbauer, S E Strome, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 4, 1999
Squamous cell carcinoma of the buccal mucosaS E Strome, W To, M Strawderman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanomaS E Strome, B Martin, D Flies, et al.
Head & Neck|October 10, 2001
Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapyD Khurana, E A Martin, J L Kasperbauer, et al.
Pageof 3